Related Experiment Video
Updated: Sep 3, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
[Infantile myasthenia gravis: report of a case diagnosed clinically]
Insights
This report details a rare case of infantile myasthenia gravis (congenital type) diagnosed in a 16-month-old child. Clinical diagnosis and positive responses to Neostigmine and Mestinon confirmed the condition.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Infantile myasthenia gravis (IMG) is a rare neuromuscular disorder.
- Congenital myasthenia gravis presents in infancy with varying clinical manifestations.
- Accurate diagnosis is crucial for timely and effective management.
Observation:
- A 16-month-old child presented with symptoms suggestive of myasthenia gravis from two months of age.
- Clinical assessment was the primary diagnostic tool.
- The patient showed immediate improvement with Neostigmine and sustained benefit with Mestinon.
Findings:
- The case represents a rare instance of congenital myasthenia gravis.
- Diagnosis was confirmed through clinical criteria and therapeutic response.
- The child responded well to anticholinesterase medication.
Implications:
- This case highlights the importance of clinical suspicion in diagnosing IMG.
- Early diagnosis and treatment with Mestinon can significantly improve outcomes.
- Understanding differential diagnoses is key for managing infantile myasthenia gravis.
Abstract:
A rare case of infantile myasthenia gravis (congenital type) is reported. The child was 16 months old at the time of the diagnosis, although she presented signs suggestive of the disease since two months earlier. The diagnosis was based solely upon clinical criteria, including immediate response to a therapeutic test with Neostigmine, followed by excellent response to treatment with Mestinon. A review of the different types of myasthenia gravis in infancy is made, with emphasis on the clinical criteria for differential diagnosis of these cases.
Related Concept Videos
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology

